Indrayani Biotech Limited (INDRANIB.BO)
INR 36.58
(0.38%)
INR 36.58
(0.38%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.66 Billion | 1.62 Billion | 615.71 Million | 210.88 Million | 498.96 Million | - |
| Cost of Revenue | 971.32 Million | 1.02 Billion | 410.42 Million | 157.71 Million | 324.8 Million | - |
| Gross Profit | 690.93 Million | 607.13 Million | 205.28 Million | 53.16 Million | 174.16 Million | - |
| Operating Expenses | 156.57 Million | 467.4 Million | 144.04 Million | 102.29 Million | 156.54 Million | 2.14 Million |
| Selling, General and Administrative Expenses | 258.35 Million | 37.84 Million | 4.09 Million | 7.15 Million | 2.59 Million | 876.05 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 7.92 Million | 1.03 Million | 1.02 Million | 1.28 Million | -2770.00 |
| Cost and Expenses | 1.46 Billion | 1.48 Billion | 554.47 Million | 260 Million | 481.34 Million | 2.14 Million |
| Operating Income | 198.63 Million | 139.62 Million | 61.22 Million | -54 Million | 17.68 Million | -1.36 Million |
| Interest Expense | 100.95 Million | 49.99 Million | 18.26 Million | 19.07 Million | 11.5 Million | 270.00 |
| Income Tax Expense | 5.51 Million | 3.75 Million | 124 Thousand | 5.28 Million | 1.2 Million | -1.61 Million |
| Earnings before Tax | 109.74 Million | 123.05 Million | 44.51 Million | -112.14 Million | 8.07 Million | -539.26 Thousand |
| Net Income | 63.64 Million | 119.3 Million | 44.39 Million | -112.14 Million | 8.07 Million | -539.26 Thousand |
| Earnings Per Share Basic | 1.63 | 3.49 | 1.30 | -3.28 | 2.22 | -0.15 |
| Earnings Per Share Diluted | 1.63 | 3.49 | 1.30 | -3.28 | 2.22 | -0.15 |
| Weighted Average Shares Outstanding | 39.04 Million | 34.22 Million | 34.22 Million | 34.22 Million | 3.64 Million | 3.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.93 Million | 34.22 Million | 34.22 Million | 34.22 Million | 3.64 Million | 3.59 Million |
| Gross Margin | 0.42 | 0.37 | 0.33 | 0.25 | 0.35 | - |
| EBIT Margin | 0.15 | 0.13 | 0.11 | -0.20 | 0.06 | - |
| Profit Margin | 0.04 | 0.07 | 0.07 | -0.53 | 0.02 | - |
| EBITDA | 244.63 Million | 180.26 Million | 68.76 Million | -87.88 Million | 27.75 Million | -538.99 Thousand |
| Earnings Before Tax Margin | 0.12 | 0.09 | 0.10 | -0.26 | 0.04 | - |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 315.27 Million | 1.66 Billion | 443.8 Million | 390.92 Million | 404.4 Million | 423.12 Million |
| Cost of Revenue | 241.3 Million | 1.24 Billion | 294.33 Million | 244.44 Million | 245.2 Million | 281.55 Million |
| Gross Profit | 73.97 Million | 413.63 Million | 149.47 Million | 146.47 Million | 159.2 Million | 141.57 Million |
| Operating Expenses | 42.48 Million | 217.21 Million | 57.34 Million | 122.4 Million | 95.33 Million | 125.21 Million |
| Selling, General and Administrative Expenses | 42.48 Million | - | 57.34 Million | 62.33 Million | 35.15 Million | 62.37 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 443 Thousand | 12.14 Million | 10.33 Million | 824 Thousand | 906 Thousand | 87 Thousand |
| Cost and Expenses | 283.78 Million | 1.46 Billion | 351.67 Million | 366.85 Million | 340.53 Million | 406.76 Million |
| Operating Income | 31.49 Million | 196.42 Million | 92.12 Million | 24.89 Million | 63.86 Million | 16.36 Million |
| Interest Expense | 22.48 Million | 98.82 Million | 55.13 Million | 14.07 Million | 9.34 Million | 20.28 Million |
| Income Tax Expense | 945 Thousand | 5.51 Million | 5.51 Million | 1.01 Million | 906 Thousand | 623 Thousand |
| Earnings before Tax | 9.44 Million | 109.74 Million | 47.32 Million | 10.82 Million | 55.42 Million | -3.83 Million |
| Net Income | 8.5 Million | 104.22 Million | 47.32 Million | 9.8 Million | 55.42 Million | -4.45 Million |
| Earnings Per Share Basic | 0.19 | - | 1.04 | 0.24 | 1.62 | -0.13 |
| Earnings Per Share Diluted | 0.19 | - | 1.04 | 0.24 | 1.62 | -0.13 |
| Weighted Average Shares Outstanding | 45.53 Million | 45.53 Million | 45.53 Million | 45.53 Million | 34.22 Million | 34.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.53 Million | 45.53 Million | 45.53 Million | 45.53 Million | 34.22 Million | 34.22 Million |
| Gross Margin | 0.23 | 0.25 | 0.34 | 0.37 | 0.39 | 0.33 |
| EBIT Margin | 0.13 | - | 0.23 | 0.09 | 0.18 | 0.06 |
| Profit Margin | 0.03 | 0.06 | 0.11 | 0.03 | 0.14 | -0.01 |
| EBITDA | 39.76 Million | - | 101.72 Million | 35.23 Million | 73.85 Million | 25.43 Million |
| Earnings Before Tax Margin | 0.10 | 0.12 | 0.21 | 0.06 | 0.16 | 0.04 |
001206
CRNZF
YKEN
ALMAS
PDPTF
1AD